AVINASH THOMAS: Open Payments
NPI 1447744594 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 43 payments from 12 companies in 2025. Trend: 2023 $1,733 · 2024 $2,265 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $232 |
| Otsuka America Pharmaceutical, Inc. | 14 | $176 |
| Lundbeck LLC | 11 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Celgene Corporation | 5 | $106 |
| Amgen Inc. | 3 | $84 |
| Solventum Corporation | 1 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: Symbravo, VYEPTI, CAPLYTA, REXULTI, ZEPOSIA, ABILIFY MAINTENA, UPLIZNA, V.A.C.ULTA.
Industry payments across CT — which companies pay providers there.
